Pharmafile Logo
Pharmafocus logo
Advanced Search

Roquette fined $4.1m for water pollution

November 20, 2012
Manufacturing and Production DoJ, EPA, Roquette

The US unit of French ingredients producer Roquette Freres has been fined $4.1m for failing to control the discharge of …

News

Boehringer licenses high-pressure production technology

November 20, 2012
Manufacturing and Production BaroFold, Boehringer Ingelheim

Boehringer Ingelheim has licensed a new technology from BaroFold which could improve the efficiency of biopharmaceutical production processes. Colorado, US-based …

News
Alex Neil

SMC put under review

November 20, 2012
Sales and Marketing Alex Neil, NICE, SMC, Scotland

The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …

News

What can pharma can learn from Steve Jobs?

November 19, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apple, Steve Jobs, pharma

 “Creativity is just connecting things. When you ask creative people how they did something, they feel a little guilty because …

Feature

Novartis treatments set for approval

November 19, 2012
Sales and Marketing Bexsaro, CHMP, Novartis, exjade

Two Novartis drugs, meningococcal vaccine Bexsero and iron chelation therapy Exjade, have been given positive opinions by the CHMP, with …

News

European nod for Sanofi drugs

November 19, 2012
Research and Development, Sales and Marketing CHMP, Sanofi

Two of Sanofi’s key drugs have cleared the penultimate hurdle to approval in Europe with a recommendation from the CHMP. …

News

Daiichi Sankyo chief executive elected NPC chairman of the Board

November 19, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo

The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …

Appointment

Implementation of IHW ‘patchy’

November 16, 2012
Sales and Marketing CCGs, IHW, NHS

An NHS initative which is supposed to drive public health forward is in danger of having only a limited impact, …

News
China pharma image

The future is bright – but don’t rely on emerging markets

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC

The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …

News

Sanofi appoints Gary Nabel as chief scientific officer

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabel, Sanofi

Sanofi has announced the appointment of Dr Gary Nabel, senior VP, chief scientific officer and deputy to the president for …

Appointment

EFPIA rejects ‘indiscriminate’ transparency

November 16, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials

Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …

News
Orchid image

Orchid exits Chinese joint venture

November 15, 2012
Manufacturing and Production North China pharma corp, Orchid

India’s Orchid Chemicals & Pharmaceuticals has ducked out of a joint venture it set up in China ten years ago …

News
jonas_jeffery_5x7_300dpi_srgb

Jeff Jonas joins Shire’s Leadership Team

November 15, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire

Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …

Appointment

UK Board appointments at Universal WorldEvents

November 15, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Healthcare events firm Universal WorldEvents has appointed Denise Abbott and Nicola Burns to its Board. Abbott (pictured) joined Universal WorldEvents …

Appointment
Forxiga image

Forxiga approved in European Union

November 15, 2012
Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes

AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …

News

Regeneron to invest $70m in NYC manufacturing

November 15, 2012
Manufacturing and Production NY, Regeneron, Sanofi, US

Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …

News
Jeremy Hunt image

Hunt: England to be technology ‘leader’

November 15, 2012
Medical Communications, Sales and Marketing Jeremy Hunt, NHS, telehealth

Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …

News
Lundbeck plant image

Lundbeck opens first Asian manufacturing plant

November 14, 2012
Manufacturing and Production China, Lundbeck

Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …

News

Germany dismisses Seroquel XR

November 14, 2012
Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …

News

No specific targets in NHS mandate

November 14, 2012
Sales and Marketing CCGs, NHS, commissioning

The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026